L3VLUP
ProSign in

ELAN in the 13F filings

Elanco Animal Health Inc · CUSIP 28414H103

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Mar 2025
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 14 May 2025
Managers listing it
6
at least, of 95 tracked, among listed positions
Comparable managers
95
filed both Q4 2024 and Q1 2025; 4 listed it in both
Shares listed
142,878,033
combined, among listed positions
Reported value
$1.5bn
combined, at the quarter end

Among the 95 comparable managers: 4 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ELAN in Q1 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

6 of 6 holders

ActionFiling
Dodge & Cox82,920,582$871m0.50%Trimmed-260,08414 May 2025 (the filing on sec.gov)
Fidelity (FMR LLC)53,858,673$566munder 0.1%Added+13,626,3465 Nov 2026 (the filing on sec.gov)
Freestone Grove Partners LP3,207,335$34m0.35%Added+1,523,14515 May 2025 (the filing on sec.gov)
Holocene Advisors LP2,236,474$23m0.07%Newnew15 May 2025 (the filing on sec.gov)
Moore Capital Management LP638,969$6.7m0.14%Newnew12 Aug 2025 (the filing on sec.gov)
Farallon Capital Management LLC16,000$168kunder 0.1%Held015 May 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2024 to Q1 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

  • Dodge & Coxexisting position · 82,920,582 shares now-260,084

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
7 in Q3 2024 to 10 in Q2 2026

Tracked managers listing it, at least.

0510152020192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ELAN by quarter
QuarterHoldersReported valueBuyersSellers
Q3 201813$388mn.a.n.a.
Q4 20187$383mn.a.n.a.
Q1 201914$3.5bnn.a.n.a.
Q2 201910$3.7bnn.a.n.a.
Q3 201913$2.9bnn.a.n.a.
Q4 201913$3.3bnn.a.n.a.
Q1 202013$2.9bnn.a.n.a.
Q2 202012$2.4bnn.a.n.a.
Q3 20206$2.9bnn.a.n.a.
Q4 202016$4.1bnn.a.n.a.
Q1 202112$4.0bnn.a.n.a.
Q2 202114$4.6bnn.a.n.a.
Q3 202110$4.0bnn.a.n.a.
Q4 202113$3.8bnn.a.n.a.
Q1 202211$3.1bnn.a.n.a.
Q2 202211$2.4bnn.a.n.a.
Q3 202215$1.9bnn.a.n.a.
Q4 202215$1.7bnn.a.n.a.
Q1 202312$1.2bnn.a.n.a.
Q2 202313$1.6bnn.a.n.a.
Q3 202312$1.7bnn.a.n.a.
Q4 20239$1.9bn29
Q1 202410$2.3bn73
Q2 20249$2.1bn64
Q3 20247$1.5bn43
Q4 20245$1.5bn22
Q1 20256$1.5bn41
Q2 20259$2.5bn82
Q3 202512$3.4bn75
Q4 20259$3.3bn1715
Q1 20265$3.0bn1516
Q2 202610$3.6bn1515

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ELAN and LLY →ELAN and JNJ →ELAN and VRTX →Choose a stock to compare with ELAN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ELAN, latest filings →Back to the 13F Explorer →